Status: Completed
ClinicalTrials.gov Identifier: NCT00913744
TG-MV-005: Ocriplasmin injection in patients with wet AMD/focal vitreomacular adhesion.
Condition:
Study Type: Interventional
Duration: 3 years & 2 months
Eligibility:
For more information on this study, please click here
Back to Clinical Research